{"id":297916,"date":"2019-10-11T22:00:10","date_gmt":"2019-10-12T05:00:10","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/10\/harbour-biomed-completes-china-phase-ii-trial-of-dry-eye-treatment\/"},"modified":"2019-10-11T22:02:18","modified_gmt":"2019-10-12T05:02:18","slug":"%e5%92%8c%e9%93%82%e5%8c%bb%e8%8d%af%e5%ae%8c%e6%88%90%e4%b8%ad%e5%9b%bd%e5%b9%b2%e7%9c%bc%e7%97%87%e6%b2%bb%e7%96%97%e4%ba%8c%e6%9c%9f%e8%af%95%e9%aa%8c","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/10\/%e5%92%8c%e9%93%82%e5%8c%bb%e8%8d%af%e5%ae%8c%e6%88%90%e4%b8%ad%e5%9b%bd%e5%b9%b2%e7%9c%bc%e7%97%87%e6%b2%bb%e7%96%97%e4%ba%8c%e6%9c%9f%e8%af%95%e9%aa%8c\/","title":{"rendered":"\u548c\u94c2\u533b\u836f\u5b8c\u6210\u4e2d\u56fd\u5e72\u773c\u75c7\u6cbb\u7597\u4e8c\u671f\u8bd5\u9a8c"},"content":{"rendered":"<p>\u548c\u94c2\u533b\u836f\u5b8c\u6210\u4e86HBM9036\uff08tanfanercept\uff09\u5728\u4e2d\u56fd\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0cHBM9036\u662f\u4e00\u79cd\u65b0\u7684TNF\u53d7\u4f531\u7247\u6bb5\uff0c\u9002\u7528\u4e8e\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u5e72\u773c\u75c5\u3002 2017\u5e74\uff0c\u548c\u94c2\u533b\u836f\u4ece\u97e9\u56fdHanAll\u83b7\u5f97\u4e86HBM9036\u7684\u4e13\u5229\u6743\uff0c\u5176\u4e2d\u8fd8\u5305\u62ec\u9488\u5bf9\u75c5\u539f\u6027IgG\u4ecb\u5bfc\u7684\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u7684\u7597\u6cd5\u3002\u548c\u94c2\u533b\u836f\u6307\u51fa\uff0c\u5904\u65b9\u5e72\u773c\u836f\u6c34\u53ef\u7f13\u89e3\u5e72\u773c\u75c7\u75c7\u72b6\uff0c\u4f46\u4e0d\u80fd\u89e3\u51b3\u6f5c\u5728\u7684\u708e\u75c7\u3002\u548c\u94c2\u533b\u836f\u603b\u90e8\u4f4d\u4e8e\u6ce2\u58eb\u987f\uff0c\u5728\u8377\u5170\u548c\u4e0a\u6d77\u8bbe\u6709\u4e1a\u52a1\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Harbour BioMed (HBM) completed a China Phase II trial of HBM9036 (tanfanercept), a novel TNF receptor-1 fragment indicated for moderate-to-severe Dry-Eye-Disease. In 2017, Harbour in-licensed China rights to the candidate in a two-drug deal from Korea&#8217;s HanAll, which also included a treatment for pathogenic IgG-mediated autoimmune diseases.<\/p>\n","protected":false},"author":9,"featured_media":297913,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,925,459],"class_list":["post-297916","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/297916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=297916"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/297916\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/297913"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=297916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=297916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=297916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}